GP Strategies Corp. (GPX) Tops Q2 EPS by 13c
Tweet
Share
E-mailGet Alerts GPX Hot Sheet
Price: $20.85 --0%
Financial Fact:
Selling, general and administrative expenses: 12M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Selling, general and administrative expenses: 12M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
GP Strategies Corp. (NYSE: GPX) reported Q2 EPS of $0.42, $0.13 better than the analyst estimate of $0.29. Revenue for the quarter came in at $134.9 million versus the consensus estimate of $121.94 million.
For earnings history and earnings-related data on GP Strategies Corp. (GPX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Telesat Corporation (TSAT) Misses Q2 EPS by 1006c
- Legence Corp. (LGN) Misses Q2 EPS by 58c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
